Internal Hemorrhoids
10
3
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
30%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Clinical Outcomes After Laser Hemorrhoidoplasty
Comparison of Laser Hemorrhoidoplasty Versus Conventional Milligan Morgan Hemorrhoidectomy in Grade II and III Hemorrhoids
Prospective HemorrhoIdaL EmboliSation (PILES) Registry
Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation
Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)
HELO Trial: Energy-Based Therapies vs. Conventional Hemorrhoidectomy for Grade III Hemorrhoids
Evaluate Safety and Efficacy of 25 mg Hydrocortisone Acetate Suppositories in Treatment of Internal Hemorrhoids
Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids
Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids
Study About Patient Comfort and Long-term Outcome After Stapled Hemorrhoidopexy